maprotiline has been researched along with Exanthem in 1 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The first 2 days patients received a high initial dosage of 300 mg per day." | 2.64 | [Clinical double-blind study with two different dosages of maprotiline (150 and 225 mg per day) (author's transl)]. ( Angst, J; Gmuer, M; Hess, K; Hurwitz, E; Martens, H; Rothweiler, R; Steiner, A; Woggon, B, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Woggon, B | 1 |
| Angst, J | 1 |
| Gmuer, M | 1 |
| Hess, K | 1 |
| Hurwitz, E | 1 |
| Martens, H | 1 |
| Rothweiler, R | 1 |
| Steiner, A | 1 |
1 trial available for maprotiline and Exanthem
| Article | Year |
|---|---|
[Clinical double-blind study with two different dosages of maprotiline (150 and 225 mg per day) (author's transl)].
Topics: Adult; Anthracenes; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Exanthem | 1976 |